Endoscope Reprocessing & Technology Advances in ERCP for the Practicing Gastroenterologist
Thursday, August 6th at 7:30 - 8:30 PM ET
Live webcast discussing the history of duodenoscope cross-contamination, FDA recommendations and new technologies.Register Now
Duodenoscope reprocessing and safety communications
There have been more FDA safety communications on duodenoscopes than any other medical device since 2013.
Subsequently the FDA mandated post market surveillance studies to monitor the effectiveness of reprocessing.
Up to 5.0% of properly collected samples tested positive for high-concern organisms, which cause diseases
Up to 4.4% of properly collected samples tested positive for enough low concern organisms to indicate a reprocessing failure